Yet, according to the COSMIC database, mutations in the SMO gene have been identified in 35 out of 45 (78%) primary cancer tissue types, which highlights the importance of further investigation into the functional role of Smo mutants in various tumours. This evidence concerns the gene SMO and cancer.